Archive: 22/10/2020

Moderna hails diversity of COVID trial participants

Biotech firm Moderna said Thursday that it had successfully recruited ethnic minorities, older people and those with underlying health issues for its COVID-19 vaccines trial, after it pushed to enrol groups most vulnerable ...

Oct 22, 2020

Dasatinib and blinatumomab active for ph-positive ALL in adults

(HealthDay)—Chemotherapy-free induction and consolidation first-line treatment with dasatinib and blinatumomab is associated with a high incidence of molecular response and survival in adults with Philadelphia chromosome ...

Oct 22, 2020

0

1

France extends COVID curfew to cover 46 million people

France on Thursday extended the anti-COVID curfew in place in nine cities to large parts of the country, leaving 46 million forced to stay indoors at night.

Oct 22, 2020

0

0

Cytokines not at 'storm' levels in those with severe COVID-19

(HealthDay)—COVID-19 may not cause a cytokine storm, according to a review published online Oct. 16 in The Lancet Respiratory Medicine.

Oct 22, 2020

0

1

Individuals may legitimize hacking when angry with system or authority

University of Kent research has found that when individuals feel that a system or authority is unresponsive to their demands, they are more likely to legitimize hacker activity at an organization's expense.

Oct 22, 2020

0

3

CDC: Number of COVID-19 deaths may be under-reported

(HealthDay)—The number of COVID-19-related deaths may be underestimated, according to research published in the Oct. 20 early-release issue of the U.S. Centers for Disease Control and Prevention Morbidity and Mortality ...

Oct 22, 2020

0

2

'Mini-lungs' reveal early stages of SARS-CoV-2 infection

'Mini-lungs' grown from tissue donated to Cambridge hospitals has provided a team of scientists from South Korea and the UK with important insights into how COVID-19 damages the lungs. Writing in the journal Cell Stem Cell, ...

Oct 22, 2020

0

1

Oxford COVID-19 vaccine follows its programmed genetic instructions, independent analysis finds

A team at Bristol University has used recently developed techniques to validate that the vaccine accurately follows the genetic instructions programmed into it by the Oxford team.

Oct 22, 2020

0

2

Researchers develop a simplified method to modify disease signaling with light

Most diseases are caused by aberrant cell signaling processes, and basic research in cell signaling is needed to identify targets for future therapeutic approaches, especially in cases where no cures or effective treatments ...

Oct 22, 2020

0

2

Details about broadly neutralizing antibodies provide insights for universal flu vaccine

New research from an immunology team at the University of Chicago may shed light on the challenges of developing a universal flu vaccine that would provide long-lasting and broad protection against influenza viruses.

Oct 22, 2020

0

48

page 4 from 13

«
»